Precigen, Inc. PGEN

7.75 0.05 0.65% as of 25 Sep
Market cap
$2.8B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(9,907.46%) (12,417.99%) (1,446.02%) (875.87%)

+8 more TTM periods

ROA
(247.40%) (286.76%) (285.69%) (334.36%)
ROIC
(24.87%) (102.06%) (425.63%) (538.41%)
Return on Tangible Assets
(285.75%) (408.82%) (468.60%) (379.08%)
Average Days of Receivables
306.78 308.51 164.41 63.64
Free Cash Flow per Share
(0.32) (0.33) (0.29) (0.25)
Free Cash Flow
(115.22) (116.96) (89.83) (75.62)
Capital Expenditures
(1.06) (1.63) (1.99) (3.00)
Piotroski F-Score
4.00 4.00 3.00 4.00
Other line items
Cash ROIC
(64.99%) (67.84%) (41.44%) (28.38%)
Accounts Receivable Turnover
2.36 2.28 3.51 6.90
Accounts Payable Turnover
1.73 2.21 0.62 0.83
Inventory Turnover
0.78 0.84 0.98 0.56
Average Days of Payables
242.15 150.43 907.01 519.93
Days of Inventory on Hand
924.26 855.56 725.08 253.99
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
37.67% 115.50% 426.82% 730.72%
Selling, General and Administrative Expense of Revenue
99.09% 249.46% 724.16% 1,006.23%
Share Based Compensation of Revenue
15.94% 37.10% 117.65% 191.71%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.34 0.30 0.20 0.17
Depreciation/Fixed assets
0.28 0.48 0.38 0.73
Capex/Depreciation
(0.29) (0.25) (0.38) (0.28)
Revenue per Share
0.24 0.09 0.03 0.02
Operating CF per Share
(0.32) (0.33) (0.28) (0.24)
Capex per Share
0.00 0.00 (0.01) (0.01)
Capex to Sales
0.01 0.05 0.21 0.48
Net Profit Margin
(392.81%) (1,213.54%) (4,436.62%) (6,750.13%)

Fold the line items

Columns are period end dates